Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy XTL Biopharmaceuticals Ltd ADR stock

Learn how to easily invest in XTL Biopharmaceuticals Ltd ADR stock.

XTL Biopharmaceuticals Ltd ADR is a biotechnology business based in the US. XTL Biopharmaceuticals Ltd ADR shares (XTLB) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in XTL Biopharmaceuticals Ltd ADR

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – XTLB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

XTL Biopharmaceuticals Ltd ADR stock price (NASDAQ: XTLB)

Use our graph to track the performance of XTLB stocks over time.

XTL Biopharmaceuticals Ltd ADR shares at a glance

Information last updated 2022-07-03.
Latest market close$1.49
52-week range$1.35 - $6.69
50-day moving average $1.81
200-day moving average $2.70
Wall St. target price$30.00
PE ratio 0
Dividend yield $0 (0%)
Earnings per share (TTM) $0.00

Buy XTL Biopharmaceuticals Ltd ADR shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy XTL Biopharmaceuticals Ltd ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

XTL Biopharmaceuticals Ltd ADR price performance over time

Historical closes compared with the close of $1.49 from 2022-07-01

1 week (2022-06-24) -4.49%
1 month (2022-06-03) -13.37%
3 months (2022-04-01) -34.65%
6 months (2022-01-03) -48.26%
1 year (2021-07-02) -62.18%
2 years (2020-07-02) -6.42%
3 years (2019-07-03) 1.866
5 years (2017-07-03) 3.39

XTL Biopharmaceuticals Ltd ADR financials

Gross profit TTM $0
Return on assets TTM -9.4%
Return on equity TTM 12.83%
Profit margin 0%
Book value $1.10
Market capitalisation $8.3 million

TTM: trailing 12 months

XTL Biopharmaceuticals Ltd ADR share dividends

We're not expecting XTL Biopharmaceuticals Ltd ADR to pay a dividend over the next 12 months.

Have XTL Biopharmaceuticals Ltd ADR's shares ever split?

XTL Biopharmaceuticals Ltd ADR's shares were split on a 1:5 basis on 9 February 2017. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your XTL Biopharmaceuticals Ltd ADR shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for XTL Biopharmaceuticals Ltd ADR shares which in turn could have impacted XTL Biopharmaceuticals Ltd ADR's share price.

XTL Biopharmaceuticals Ltd ADR share price volatility

Over the last 12 months, XTL Biopharmaceuticals Ltd ADR's shares have ranged in value from as little as $1.35 up to $6.69. A popular way to gauge a stock's volatility is its "beta".

XTLB.US volatility(beta: 1.04)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while XTL Biopharmaceuticals Ltd ADR's is 1.0439. This would suggest that XTL Biopharmaceuticals Ltd ADR's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

XTL Biopharmaceuticals Ltd ADR overview

XTL Biopharmaceuticals Ltd. , a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995.

Frequently asked questions

What percentage of XTL Biopharmaceuticals Ltd ADR is owned by insiders or institutions?
Currently 14.448% of XTL Biopharmaceuticals Ltd ADR shares are held by insiders and 8.483% by institutions.
When does the fiscal year end for XTL Biopharmaceuticals Ltd ADR?
XTL Biopharmaceuticals Ltd ADR's fiscal year ends in December.
Where is XTL Biopharmaceuticals Ltd ADR based?
XTL Biopharmaceuticals Ltd ADR's address is: 5 Badner Street, Ramat Gan, Israel, 5218102
What is XTL Biopharmaceuticals Ltd ADR's ISIN number?
XTL Biopharmaceuticals Ltd ADR's international securities identification number is: US98386D3070
What is XTL Biopharmaceuticals Ltd ADR's CUSIP number?
XTL Biopharmaceuticals Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 98386D109

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site